Sickle molecular Flashcards
1
Q
sickle cell mutation
A
- chromosome 11
- pt mutation A to T
- glu to val
2
Q
HbS
A
- reside 6 is now Val
- deoxygenation HbS forms 14 stranded polymers
- when well oxygenated returns to normal tetramers
- some cells remain irreversible
3
Q
hallmarks
A
- cycling b/n biconcave and sickled shape-weakens PM
- resulting RBC hemolysis (anemia) and vasoocclusion-ischemia, pain
- some sickle cells locked in sickle shape even when cell has o2 and in monomer
- 2-40% of circulating RBCs in homozygotes
4
Q
vasooculsion
A
- disease is polygenic on 2,6, and 11
- varies extent of inflammation and vasculopathy
- vasoocclusion is altered RBCs, leukocytes, BV endo cells and plasma factors
- RBCs and WBCs latch to endo and then to each other
5
Q
sickle cell crises
A
- those with less than 1 per year have a much longer life span than those with 1-3 or more than 3 per year
- 15 year difference
- molecular basis and biomarkers?
6
Q
expression of globins
A
- alpha is on 16, beta on 11
- erythropoiesis yolk sac in embyonic development, midway through 1st trimester to liver, then bone marrow at birth
- LCR for beta cluster
- embryonic to fetal gamma and alpha gamma at switch to liver
- feta gamma and alpha gamma to beta at birh
- beta genes are linearly arranged from 5’-3’ with a distal LCR directing expression
7
Q
HbF and sickle cell severity
A
- 3 loci associated with HbF levels and B globin disorder severity
- b cluster itself (cis acting haplotype on 11), HBS1l-MYB, and BCL11A
- bind to other TFs and complexes switch gamma to beta
- variants of the TFs that cause high HbF levels are clinically less severe
8
Q
BCL11A
A
- TF
- trans acting
- gamma globin silencer
- chromosome 2
9
Q
HBS1L-MYB
A
- intergenic interval on chromosome 6
- MYB influences HbF expression
- TF that represses gamma globin
10
Q
SNPs
A
- SNPs on the TFs on chromosomes 2 and 6 can increase HbF
- if around 20%, less severe form of disease
11
Q
haplotypes in the beta globin gene cluster
A
- HbS on 5 different B globin like gene cluster haplotypes which contain a polymorphism acting cis that regulates HbF
- 5 different mutations have different regulations og HbF
- Africa, Middle East, and India
- severe disease order goes Bantu, Benin, Senegal, Arab Indian
- Amount of HbF goes opposite way-most in Arab Indian
12
Q
Inflammation and vasculopathy
A
- ischemia reperfusion cycle
- vasoocclusion and ischemia cause a metabolic change, which leads to a burst of ROS when blood flow restored
- during ischemia, XO increased, upon reperfusion XO converts o2 to superoxide radical
- burst of ROS from endo cells (RBCs), adherent leukocytes and XO on endo surface
- ROS leads to NFkB, IF and cytokines, activation of leukocytes, increased adhesion molecules, further plugging, decreased NO–>abnormal endo dependent vasodilation
13
Q
sickle cell in double jeopary
A
- sickle cell RBCs contain 3x as much o2 radicals compared to normal RBCs
- they also have very low levels of reduced glutathione, particularly in highest density RBCs
- highest density, most damaged, lease antioxidants
14
Q
ROS and antioxidants
A
- RBC susceptible to oxidative damage because always carrying o2 at various po2s
- o2 radical (which comes from Fe II-III, which happens faster in sickle cells, with o2 on- superoxide) changed to h2o2 by super oxide dismutase
- h2o2 degraded by catalase, glutathione peroxidase (GPX), perioxiredoxin2, or reoxidation of Fe (makes OH radical-bad)
- normally radicals degraded to below toxic levels
- RBCs also sink for o2 radicals produced by other cell types
15
Q
metHb
A
- lower affinity for heme
- released hemin and free iron on cytoplasmic surface
- hemin or free FE can convert h2o2 into OH radical by catalyzing Fenton reaction or in concert with o2 radical by Haber Weiss reaction
- this is in sickle cell not as much in normal because Fe II to Fe III slower
16
Q
glutathione
A
- reduced and becomes oxidized when degrading h2o2
- non enzymatic
17
Q
Increased ROS and RNS in sickle cell
A
- increased antioxidation of HbS into metHb and o2 radical
- h2o2 in contact with met causes release of heme and iron more readily-catalyzed to OH radical by Fenton and Haber-Weiss
- superoxide binds NO
- released cell free HbS binds NO, limits is vasodilitory, anti IF, and antithrombotic properties–>ince in BV endo activation and ROS release
- ischemia-reperfusion-increased XO-inc NADPH oxidase-ince superoxide
- PMNs produced ROS in inc IF in NADPH oxidase dependent resp burst
18
Q
reduced antioxidant activity in SCD
A
- increased SOD–inc h2o2 and OH rad
- GPX and catalase activity reduced
- GSH reduced and inversely proportional to density-highest density are most damaged and have least GSH
19
Q
cysteine modifications and oxidative stress
A
- in presence of h2o2, thiolate can be converted to sulfenic acid (SOH)
- SOH will react with neighboring cys or GSH and create SS bonds, or make a sulfenamide
- under increased stress SOH tp sulfinic acid (SO2H) or sulfonic acid (SO3H)-irreversible damage
20
Q
scramblase
A
- works with flipase to keep phospholipids on the right side
- lose phosphatidyl symmetry across membrane because scramblase is damaged and therefore flipase unopposed
- patches of neg charged head group on outer leaflet
- associates with clotting factors and lead to hypercoag and thrombosis
- also recognition site for macrophage association
21
Q
RBC membrane skeleton
A
- spectrin responsible for shape and elasticity
- spectrin is antiparallel ab heterodimer forms tetramer by head to head linkage
- tails attach to actin protofilaments (14 g actin monomers long)
- protein 4.1 binds to tails of b spectrin
- adducin binds to B spectrin and F actin-both to reinforce spectrin/actin
- attached to lipid bilayer by protein 4.1 to glycophorin C
- and ankryin from B spectrin to transmembrane proteins B and 3
22
Q
bonds in skelton
A
- spectrin binds to actin
- adducin binds to spectrin and actin to bridge
- 4.1 binds to spectrin and membrane and actin
- ankyrin binds to spectrin and membrane
23
Q
normal actin vs ISC actin
A
- disulfide bridge b/n cys 284 and cys 373
- post translation modification
- polymerize and depolymerize more slowly than normal, can still bind spectrin
- just disassemble slowly
24
Q
spectrin
A
- self ubiquitinator- E2/E3
- normally puts 2 ub on 20 cys and links to 21 K
- SCA-no ub- E2/3 doesn’t work because oxidation of cysteines
- makes tighter RBC skeleton, can’t dissociate
- cysteine locations correspond to B2 and B1, which contain protein 4.1 and adducin binding domains
- no ub, tighter, no room for adducin/ protein 4.1 to move, no dissociation (normal spectrin/adducin (4.1)/actin binding is roomy)
25
Defects on ISC membrane
- skeleton disassembles and reassembles slowly because:
1. B actin SS bridge-actin dissembles slowly or not at all
2. diminished Ub-tighter spectrin/actin/4.1 and spectrin/adducin/actin
- locked in sickle shape
26
Dense?
- deoxygenation of RBCs (dehydration and inc corpuscular Hg)-->HbS polymerization and sickling-->sickling induced leak channel
- Ca++ in-->K+channel open
- K+ loss from channel and from leak itself
- Mg+ loss-->KCl cotransport activation
- all leads to even more dehydration
27
two step model (dense and lock) step 1
1. decreasing GSH levels-->dehydration (K+leak) and dense
-NAC blocks lower GSH induced sickle cell K+ efflux and dehydration
-oxidative damage to K+Gardos pathway (which causes leaking and is from increased ROS due to low GSH) can be reversed with NAC, which decreases GSSG:GSH (more GSH, less dehydration)
-highest density have <1% of the GSH found in low density cells
following events:
1. lowering intracellular GSH keads to increased [ ] of O2 radicals and reversible oxidative damage to Gardos channel
2. oxidative damage to Gardos leads to increased K+ loss and dehydration
3. NAC raises GSH and is antioxidant, can reverse oxidative damage
28
two step model step 2
2. second step is locking of dense cells
- occurs due to oxidative damage of actin and lack of ub on spectrin- both caused by diminished GSH (SS on actin and SS on spectrin)
- both partially reversible with NAC- antioxidant that raises GSH- no SS on actin or spectrin
- in vitro reduces SS on actin
29
NAC
- 2400 mg/day
- inc GSH
- dec dense cells
- dec ISC
- dec crises
- *may have just found that NAC may stop scramblase, which would bring serine symmetry back to bilayer
30
other treatments
- antibiotics
- analgesics
- hydroyxurea
- blood and bone marrow stem cell therapeutics
31
future treatments
- effect K leakage from RBSc-senicapoc
- effect NO levels-statins
- effect oxidative stress-NAC
- effect adhesion-statins
- effect IF-lovastatin
- effect HbF levels-decitabine
- replace defective gene
32
biomarkers
- identification of 20 monocyte proteins whose levels are highly correlated with 5 year crisis rates
- decreased apolipoprotein A1 in plasma correlated with sickle cell associated pulm hypertension and acute pain episodes
- increased microRNA mir144 leads to low antioxidant capacity, increase oxidative stress, and more sever phenotype as measured by increase hemolysis, lower Hb [ ] and higher % reticulocytes
- use in longitudinal trials to see how early they can predict severity
- personalized medicine